Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-176,100
Closed -$4.37M 2933
2025
Q2
$4.37M Sell
176,100
-197,929
-53% -$4.98M 0.02% 596
2025
Q1
$11.1M Buy
374,029
+326,498
+687% +$9.53M 0.07% 216
2024
Q4
$1.29M Sell
47,531
-122,061
-72% -$3.63M 0.01% 947
2024
Q3
$5.11M Buy
169,592
+118,061
+229% +$3.73M 0.03% 450
2024
Q2
$1.71M Buy
+51,531
New +$1.76M 0.01% 790
2023
Q1
Sell
-117,531
Closed -$3.41M 2565
2022
Q4
$3.41M Buy
117,531
+105,314
+862% +$2.91M 0.05% 380
2022
Q3
$239K Buy
+12,217
New +$252K ﹤0.01% 2133
2021
Q4
Sell
-22,260
Closed -$497K 3282
2021
Q3
$497K Buy
+22,260
New +$509K ﹤0.01% 1995
2018
Q4
Sell
-11,557
Closed -$503K 610
2018
Q3
$503K Buy
+11,557
New +$484K 0.08% 172

Other funds holding CHX

HRT Financial's CHX Position: Q3 2025 in Review

HRT Financial sold out of ChampionX (CHX) in Q3 2025, closing a stake of 176,100 shares — an estimated $4.37M sold.

HRT Financial first reported a position in CHX in Q3 2018 and held it in 9 quarters. The position peaked at $11.1M in Q1 2025. 3 funds tracked by Wall St. Rank hold CHX as of Q3 2025.

  • HRT Financial reported no remaining ChampionX position as of Q3 2025 after selling out during the quarter.
  • HRT Financial sold 176,100 ChampionX shares in Q3 2025, an estimated $4.37M.
  • HRT Financial first reported a position in ChampionX in Q3 2018 and held it in 9 quarters.
  • HRT Financial's ChampionX position peaked at $11.1M in Q1 2025.
  • 3 funds tracked by Wall St. Rank held ChampionX as of Q3 2025.

Based on HRT Financial's 13F filing for Q3 2025, filed 14 Nov 2025.